Davinci Rejuvenation Clinique LLC is categorized under Physicians Offices in Osprey, FL and active since 2012.
Davinci Rejuvenation Clinique LLC was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Rosetta Cannata at the company’s single location by writing to 134 Marys Chapel Court, Osprey, Florida FL 34229 or by phoning (941) 780-0092. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Davinci Rejuvenation Clinique LLC |
| Contact Person: | Rosetta Cannata |
| Address: | 134 Marys Chapel Court, Osprey, Florida 34229 |
| Phone Number: | (941) 780-0092 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physicians Offices |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Davinci Rejuvenation Clinique LLC was started in 2012 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Rosetta Cannata for inquiries that concern Davinci Rejuvenation Clinique LLC by calling the company number (941) 780-0092, as your correspondence is most welcome. Additionally, the physical location of the single location of Davinci Rejuvenation Clinique LLC can be found at the coordinates 27.202509,-82.492815 as well as the street address 134 Marys Chapel Court in Osprey, Florida 34229.
For its online presence, you may visit Davinci Rejuvenation Clinique LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.